Drug Shortage Report for MAR-PALIPERIDONE
Report ID | 150913 |
Drug Identification Number | 02511010 |
Brand name | MAR-PALIPERIDONE |
Common or Proper name | MAR-Paliperidone |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | PALIPERIDONE |
Strength(s) | 3MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | Bottle x 100 Tabs |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-11-11 |
Actual start date | 2021-11-11 |
Estimated end date | 2022-08-31 |
Actual end date | 2021-11-01 |
Shortage status | Avoided shortage |
Updated date | 2023-07-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-07-13 | French | Compare |
v3 | 2023-07-13 | English | Compare |
v2 | 2021-12-10 | French | Compare |
v1 | 2021-12-10 | English | Compare |
Showing 1 to 4 of 4